| Oct 19 |
Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments
|
| Oct 18 |
Amylyx’s AMX0035 shows promise in Phase II Wolfram syndrome trial
|
| Oct 18 |
Why Amylyx Pharmaceuticals Stock Was So Healthy This Week
|
| Oct 18 |
PTC rebuffed again by EMA; Novartis licenses China-based biotech’s cancer drug
|
| Oct 17 |
Amylyx Pharmaceuticals reports results from pancreatic disease treatment trial
|
| Oct 17 |
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
|
| Oct 15 |
Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024
|
| Oct 9 |
Amylyx Pharmaceuticals Inc (AMLX) Q2 2024 Earnings Call Highlights: Strategic Pipeline ...
|
| Sep 9 |
Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
|
| Sep 9 |
Amylyx Pharmaceuticals: Management Ambitiously Navigates Challenges
|
